Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for PEXIDARTINIB HYDROCHLORIDE
- A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in Japan
- Study to Evaluate Discontinuation and Re-Treatment in Participants With Tenosynovial Giant Cell Tumor (TGCT) Previously Treated With Pexidartinib
- A Study of the Efficacy and Safety of Pexidartinib in Adult Subjects With TGCT
- Study of Pexidartinib in Participants With Moderate Hepatic Impairment Compared With Healthy Participants
- Effect of Low-Fat Food on Pexidartinib Pharmacokinetics in Healthy Volunteers
- Effect of Pexidartinib on the Way the Body Processes CYP3A4 and CYP2C9 Substrates (Pharmacokinetics)
- A Study of MEK162 (Binimetinib) in Combination With Pexidartinib in Patients With Advanced Gastrointestinal Stromal Tumor (GIST)
- Effect of Probenecid on Pexidartinib Pharmacokinetics
- A Study of PLX3397 in Patients With Unresectable or Metastatic KIT-mutated Melanoma
- Evaluation of Safety and Activity of an Anti-PDL1 Antibody (DURVALUMAB) Combined With CSF-1R TKI (PEXIDARTINIB) in Patients With Metastatic/Advanced Pancreatic or Colorectal Cancers
- Study of Pexidartinib in Asian Subjects With Advanced Solid Tumors
- A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors
- CGT9486 (Formerly Known as PLX9486) as a Single Agent and in Combination With PLX3397 (Pexidartinib) or Sunitinib in Participants With Advanced Solid Tumors
- Phase 3 Study of Pexidartinib for Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCT-TS)
- A Phase 1b/2 Study of PLX3397 + Radiation Therapy + Temozolomide in Patients With Newly Diagnosed Glioblastoma
- Safety Study of PLX3397 and Paclitaxel in Patients With Advanced Solid Tumors
- A Phase 2 Study of PLX3397 in Patients With Recurrent Glioblastoma
Clinical trials list
click for details